The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man

R A DeFronzo, C R Cooke, R Andres, G R Faloona, P J Davis, R A DeFronzo, C R Cooke, R Andres, G R Faloona, P J Davis

Abstract

The effects of insulin on the renal handling of sodium, potassium, calcium, and phosphate were studied in man while maintaining the blood glucose concentration at the fasting level by negative feedback servocontrol of a variable glucose infusion. In studies on six water-loaded normal subjects in a steady state of water diuresis, insulin was administered i.v. to raise the plasma insulin concentration to between 98 and 193 muU/ml and infused at a constant rate of 2 mU/kg body weight per min over a total period of 120 min. The blood glucose concentration was not significantly altered, and there was no change in the filtered load of glucose; glomerular filtration rate (CIN) and renal plasma flow (CPAH) were unchanged. Urinary sodium excretion (UNaV) decreased from 401 plus or minus 46 (SEM) to 213 plus or minus 18 mueq/min during insulin administration, the change becoming significant (P smaller than 0.02) within the 30-60 min collection period. Free water clearance (CH2O) increased from 10.6 plus or minus 0.6 to 13 plus or minus 0.5 ml/min (P smaller than 0.025); osmolar clearance decreased and urine flow was unchanged. There was no change in plasma aldosterone concentration, which was low throughout the studies, and a slight reduction was observed in plasma glucagon concentration. Urinary potassium (UKV) and phosphate (UPV) excretion were also both decreased during insulin administration; UKV decreased from 66 plus or minus 9 to 21 plus or minus 1 mueq/min (P smaller than 0.005), and tupv decreased from 504 plus or minus 93 to 230 plus or minus 43 mug/min (P smaller than 0.01). The change in UKV was associated with a significant reduction in plasma potassium concentration. There was also a statistically significant but small reduction in plasma phosphate concentration which was not considered sufficient alone to account for the large reduction in UPV. Urinary calcium excretion (UCaV) increased from 126 plus or minus 24 to 200 plus or minus 17 mug/min (P smaller than 0.01). These studies demonstrate a reduction in UNaV associated with insulin administration that occurs in the absence of changes in the filtered load of glucose, glomerular filtration rate, renal blood flow, and plasma aldosterone concentration. The effect of insulin on CH2O suggests that insulin's effect on sodium excretion is due to enhancement of sodium reabsorption in the diluting segment of the distal nephron.

References

    1. J Clin Invest. 1933 Mar;12(2):297-326
    1. Am J Physiol. 1959 Aug;197:337-41
    1. J Clin Invest. 1960 Jul;39:1157-75
    1. Arch Intern Med. 1960 Sep;106:321-6
    1. J Clin Invest. 1962 Jan;41:108-15
    1. J Clin Invest. 1955 Oct;34(10):1520-3
    1. Metabolism. 1965 Jan;14:31-46
    1. Am J Physiol. 1964 Apr;206:674-86
    1. Proc Soc Exp Biol Med. 1964 Jan;115:29-32
    1. Am J Physiol. 1963 Oct;205:697-701
    1. Metabolism. 1963 Sep;12:804-11
    1. J Lab Clin Med. 1962 Sep;60:422-32
    1. Ann N Y Acad Sci. 1962 Oct 31;102:46-54
    1. Biochim Biophys Acta. 1963 Jan 15;66:170-2
    1. Metabolism. 1962 Mar;11:329-36
    1. Arch Intern Med. 1962 Jan;109:26-32
    1. Am J Physiol. 1960 Mar;198:599-602
    1. Am J Physiol. 1961 May;200:1099-104
    1. J Clin Endocrinol Metab. 1958 Aug;18(8):813-24
    1. Proc Soc Exp Biol Med. 1957 Jan;94(1):57-60
    1. J Appl Physiol. 1954 Feb;6(8):509-12
    1. Am J Physiol. 1973 May;224(5):1136-42
    1. Am J Physiol. 1971 Oct;221(4):1192-208
    1. J Clin Invest. 1973 Dec;52(12):3028-32
    1. Arch Int Physiol Biochim. 1969 Aug;77(3):527-30
    1. Diabetes. 1974 Mar;23(3):240-6
    1. Kidney Int. 1973 Jan;3(1):24-9
    1. J Clin Invest. 1974 May;53(5):1481-92
    1. J Clin Invest. 1974 May;53(5):1424-33
    1. Kidney Int. 1973 Dec;4(6):369-76
    1. Diabetes. 1973 Sep;22(9):676-86
    1. J Clin Endocrinol Metab. 1973 Apr;36(4):761-5
    1. Eur J Clin Invest. 1972 Nov;2(6):439-44
    1. Kidney Int. 1972 Aug;2(2):76-84
    1. N Engl J Med. 1971 Aug 19;285(8):443-9
    1. Clin Chem. 1967 Feb;13(2):101-14
    1. Eur J Clin Invest. 1970 Mar;1(1):25-31
    1. Metabolism. 1971 Dec;20(12):1065-73
    1. Med Clin North Am. 1971 Jul;55(4):835-46
    1. Pflugers Arch. 1971;323(1):11-20
    1. J Gen Physiol. 1971 May;57(5):495-525
    1. J Clin Invest. 1970 Dec;49(12):2256-70
    1. Metabolism. 1970 Dec;19(12):1119-28
    1. J Clin Invest. 1970 Jul;49(7):1458-65
    1. J Lab Clin Med. 1969 Dec;74(6):915-26
    1. Clin Sci. 1969 Apr;36(2):267-82
    1. J Clin Endocrinol Metab. 1969 Jan;29(1):55-62
    1. J Lab Clin Med. 1968 Jul;72(1):93-104
    1. Am J Physiol. 1968 Jan;214(1):52-7
    1. J Biol Chem. 1967 Aug 25;242(16):3731-6
    1. Am J Physiol. 1967 Nov;213(5):1218-24
    1. J Lab Clin Med. 1967 Oct;70(4):563-70
    1. J Clin Invest. 1967 Jul;46(7):1178-88
    1. J Lab Clin Med. 1967 Aug;70(2):236-45
    1. Metabolism. 1967 Apr;16(4):358-73
    1. Am J Physiol. 1966 Sep;211(3):529-47

Source: PubMed

3
Předplatit